[Federal Register Volume 62, Number 198 (Tuesday, October 14, 1997)]
[Notices]
[Pages 53355-53356]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-27040]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration; (Nu-Tech Bio-Med, Inc., Common Stock, $.01 Par Value) 
File No. 1-13900

October 7, 1997.
    Nu-Tech Bio-Med, Inc. (``Company'') has filed an application with 
the Securities and Exchange Commission (``Commission''), pursuant to 
Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and Rule 
12d2-2(d) promulgated thereunder, to withdraw the above specified 
security (``Security'') from listing and registration on the Boston 
Stock Exchange, Inc. (``BSE'' or ``Exchange'').
    The reasons cited in the application for withdrawing the Security 
from listing and registration include the following:
    In making the decision to withdraw its Security from listing on the 
BSE, the Company considered the direct and indirect costs and expenses 
attendant on maintaining the dual listing of its Security. The Company 
does not see any particular advantage in the dual trading of its 
securities.
    The Company has complied with the Rules of the BSE by filing with 
such Exchange details of the reasons for such proposed withdrawal, and 
the facts in support thereof.
    By letter dated September 22, 1997, the BSE informed the Company 
that the Exchange has no objection to the withdrawal of the Company's 
Security from listing on the BSE.
    Any interested person may, on or before October 29, 1997, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, N.W., Washington, D.C. 20549, facts bearing upon whether 
the application has been made in accordance with the rules of the 
exchange and what terms, if any, should be imposed by the Commission 
for the protection of investors. The Commission, based on the 
information submitted to it, will issue an order granting the 
application after the date mentioned above, unless the Commission 
determines to order a hearing on the matter.


[[Page 53356]]


    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 97-27040 Filed 10-10-97; 8:45 am]
BILLING CODE 8010-01-M